John L. Lamattina
Director at Ligand Pharmaceuticals; Director at Immunome. Based in Jupiter, Florida.
- Rank
- 9629th of 14,644
- Companies held
- 2
- Largest holding
- LGND, 87.4% of total
- Latest SEC filing
- Jun 10, 2026
What the $8.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals LGND Common Stock | Directly | 26,969 | $286.94 | $7.7M | 87.4% | Form 4, Jun 10, 2026 |
| Immunome IMNM Common Stock | Directly | 66,953 | $16.61 | $1.1M | 12.6% | Form 4, Jan 15, 2023 |
Share counts are the amounts John L. Lamattina reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Sold | LGND | 257 | $247.22 | $64K | View |
| Jun 10, 2026 | Sold | LGND | 3,405 | $251.62 | $857K | View |
| Jun 10, 2026 | Sold | LGND | 697 | $249.53 | $174K | View |
| Jun 10, 2026 | Sold | LGND | 232 | $248.11 | $58K | View |
| Mar 6, 2026 | Sold | LGND | 2,161 | $200.76 | $434K | View |
| Nov 7, 2025 | Sold | LGND | 2,034 | $205.45 | $418K | View |
| Nov 7, 2025 | Sold | LGND | 2,145 | $205.45 | $441K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 9626 | Jeffrey K. Li SVP and Secretary, Keysight Technologies. Santa Rosa, CA | $8.9M |
| 9627 | John G. Freund Director, SI-BONE. Santa Clara, CA | $8.9M |
| 9628 | Mariani Gustavo Vice President, Pampa Energía | $8.9M |
| 9629 | John L. Lamattina Director, Ligand Pharmaceuticals. Jupiter, FL | $8.9M |
| 9630 | Ryan F. Urness SVP, GC & Secretary, Dycom Industries. West Palm Beach, FL | $8.8M |
| 9631 | Robert A Cashell Jr Director, Glacier Bancorp. Kalispell, MT | $8.8M |
| 9632 | Bruce John Essex Jr. Director, ChoiceOne Financial Services. Sparta, MI | $8.8M |
Other Ligand Pharmaceuticals insiders
All LGND insiders- John L. Higgins$120MDirector. #1162 overall
- Matthew W. Foehr$74.6MInsider. #1498 overall
- Todd C. Davis$57.2MChief Executive Officer. #1695 overall
- Jason Aryeh$31.7MDirector. #3493 overall
- Matthew E. Korenberg$14.6MPresident & COO. #6393 overall
- Sunil Patel$13.3MInsider. #6658 overall
Questions
How much stock does John L. Lamattina own?
John L. Lamattina holds $8,850,574 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 9629th on the Stock Rich List.
Is this John L. Lamattina's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John L. Lamattina last buy or sell stock?
The most recent open-market trade on file is a sale of 257 LGND shares on Jun 10, 2026 at $247.22.